Comments to FDA: Contract Manufacturing Quality Agreements Share page: Docket Number: FDA-2013-D-0558 CHPA's comments on this Draft Guidance are organized into three General Comments and Detailed Comments by Section. Download Document Issues: OTC Medicines Other Issues Quality Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024